Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95M Hold
16,498
0.02% 254
2026
Q1
$1.97M Buy
16,498
+75
+0.5% +$9.84K 0.02% 242
2025
Q4
$2.24M Hold
16,423
0.03% 206
2025
Q3
$2.42M Hold
16,423
0.05% 177
2025
Q2
$2.12M Sell
16,423
-3,030
-16% -$367K 0.05% 179
2025
Q1
$2.32M Buy
19,453
+3,030
+18% +$375K 0.06% 168
2024
Q4
$1.91M Hold
16,423
0.05% 170
2024
Q3
$2.22M Hold
16,423
0.06% 160
2024
Q2
$2.23M Hold
16,423
0.07% 162
2024
Q1
$2.12M Buy
+16,423
New +$1.98M 0.07% 167

Other funds holding XYL

Allianz's XYL Position: Q2 2026 in Review

Allianz held its Xylem (XYL) position steady in Q2 2026 at 16,498 shares worth $1.95M. The position accounts for 0.02% of the portfolio, ranked #254.

Allianz first reported a position in XYL in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.42M in Q3 2025. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Allianz held 16,498 shares of Xylem worth $1.95M as of Q2 2026.
  • Allianz left its Xylem share count unchanged in Q2 2026.
  • Xylem made up 0.02% of Allianz's portfolio in Q2 2026, its #254 holding.
  • Allianz first reported a position in Xylem in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Xylem position peaked at $2.42M in Q3 2025.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.